Labcorp

Testosterone plays an important role in women’s health. It influences muscle strength, mood and more. Discover what high or low levels could mean for you. https://bit.ly/484O6wU

We’re thrilled to be recognized as one of Forbes’ America’s Dream Employers for 2026! This recognition reflects our commitment to creating an environment where people feel inspired, supported, and empowered to do their best work. Thank you to our incredible team for making this possible. https://lnkd.in/eWBy-hpD

Labcorp® Plasma Detect™ is helping doctors see what traditional tests can miss—tiny traces of cancer that remain after treatment. Catching these signals early can guide the next steps in care. Recent studies show this approach could improve outcomes for people facing some of the toughest cancers, from rare mesothelioma to head and neck cancers. Learn more: https://bit.ly/3Kb0bso

Somatic tumor testing and hereditary cancer genetic testing work together to personalize cancer diagnostics and care. In our latest webinar, we explore how these complementary insights enable more precise treatment decisions—redefining oncology, one patient at a time. Watch now https://bit.ly/4phlRCb

A meaningful step forward in expanding access to safe, informed options for women navigating menopause.

Molecular diagnostics isn’t just a tool—it’s the foundation of precision medicine and better patient outcomes. As technologies evolve and discoveries accelerate, AMP stands at the center of this transformation, bringing together the brightest minds in healthcare and industry. Join Dr. Kyle C. Strickland, MD, PhD, director of medical affairs at Labcorp, for a behind-the-scenes look at AMP and the innovations shaping the future of diagnostics. If you’re at AMP, come find us in booth 713—we’d love to connect!

Congratulations to Anita Graham, EVP and Chief Human Resources Officer at Labcorp, on being named one of N2Growth’s Top CHROs! Anita’s leadership continues to inspire, and her commitment to cultivating a learning mindset and driving meaningful value across our organization is a testament to the power of HR in shaping the future of business. https://lnkd.in/eAYZZbja

This year, the FDA granted clearance to two blood tests for Alzheimer’s disease–pTau-217/Beta Amyloid 42 Ratio and pTau-181–designating them as in vitro diagnostic (IVD) devices. Labcorp previously released both tests as laboratory-developed tests (LDTs). So what's the difference between an IVD and LDT? Read the blog to understand the similarities and differences and what they mean: https://bit.ly/489fgDX

Today, we honor the courage, sacrifice and service of all veterans. At Labcorp, we’re proud to support those who have served and continue to make a difference every day. #VeteransDay

Deliver more inclusive research with Labcorp’s decentralized clinical trial (DCT) solutions, helping keep every sample and every patient connected. See how our DCT solutions can help your studies recruit and retain more patients. https://bit.ly/3WJxndn